Sanger, Illumina Team Sequences Tasmanian Devil Genome | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from the Wellcome Trust Sanger Institute and Illumina announced that they have sequenced a draft version of the Tasmanian devil genome as well as a pair of cancer genomes from animals with Tasmanian devil facial tumor disease, a transmissible cancer plaguing wild devils.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.